| 영문 | immune system | 한글 | 면역체계 |
|---|---|---|---|
| 설명 | 세포성분 및 분자성분의 복합체계로서, 이의 일차기능은 자기(self)를 비자기(not self)로부터 구별하고 외부생물 또는 물질에 대해 방어하는 것이다. 일차적인 세포성분은 림프구와 큰포식세포이며 일차적인 분자성분은 항체와 림포카인이다. |
||
| FAB classification | French, American, British classification |
|---|---|
| FAB | fast atom bombardment; formalin ammonium bromide; fragment, antigen-binding [of immunoglobulins]; Fr... |
| Fab | fragment, antigen-binding [of immunoglobulins] |
| DIG | digitalis; digoxin; drug-induced galactorrhea |
| dig | digitalis; digoxin |
| DLIF | Digoxin like immunoreactive factor |
|---|---|
| DLIS | Digoxin-like immunoreactive substance |
| SDC | Serum digoxin concentration |
| FAB | Fast Atom Bombardment |
| FAB-MS | Fast Atom Bombardment Mass Spectrometry |
| digoxin | <chemical> A cardiotonic glycoside obtained mainly from digitalis lanata; it consists of three sugars and the aglycone digoxigenin. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. Pharmacological action: anti-arrhythmia agents, cardiotonic agent, enzyme inhibitors. Chemical name: Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- (12 Dec 1998) |
|---|---|
| digoxin toxicity | A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor. Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels. (27 Sep 1997) |
| immunoglobulins, fab | Antigen-binding fragments composed of one entire light chain and about half of one of the heavy chains, linked to each other by disulfide bonds. Fab contains the antigen binding site which is part of the variable region of the immunoglobulin molecule. (12 Dec 1998) |
| Fab | <immunology> Fragment of immunoglobulin prepared by papain treatment. Fab fragments (45 kD) consist of one light chain linked through a disulphide bond to a portion of the heavy chain and contain one antigen binding site. They can be considered as univalent antibodies. (18 Nov 1997) |
| FAB classification | <haematology> The classification of acute myeloid leukaemia on the basis of bone marrow and peripheral blood features. M0: Acute myeloid leukaemia with minimal evidence of myeloid differentiation. M1: Acute myeloblastic leukaemia. M2: Acute myeloblastic leukaemia with differentiation. M3: Acute promyelocytic leukaemia. M4: Acute myelomonocytic leukaemia. M5: Acute monocytic leukaemia. M6: Acute erythroleukaemia. M7: Acute megakaryocytic leukaemia. Acronym: FAB (07 Apr 1998) |
| Fab fragment | The antigen-binding fragment of an immunoglobulin molecule, consisting of both a light chain and part of a heavy chain. Synonym: Fab piece. (05 Mar 2000) |
| Fab piece | The antigen-binding fragment of an immunoglobulin molecule, consisting of both a light chain and part of a heavy chain. Synonym: Fab piece. (05 Mar 2000) |
| rabies immune globulin | Globulin fraction of pooled plasma of high anti-rabies virus titre from immunised persons. Synonym: rabies immunoglobulin. (05 Mar 2000) |
| measles immune globulin | A sterile solution of globulin's derived from the blood plasma of normal adult human donors; it is prepared from immune serum globulin that complies with the measles antibody reference standard; a passive immunizing agent. Synonym: measles immunoglobulin. (05 Mar 2000) |
| cellular immune theory | A concept, put forth by Elie Metchnikoff, that cells, not antibodies, were responsible for the immune response of an organism. (05 Mar 2000) |
| rho(d) immune globulin | Immunizing agent containing IgG anti-rho(d) used for preventing rh immunization in rh-negative individuals exposed to rh-positive red blood cells. (12 Dec 1998) |
| chickenpox immune globulin | Globulin fraction of serum from persons recently recovered from herpes zoster infection; used to prevent infection of high-risk children. Synonym: chickenpox immunoglobulin. (05 Mar 2000) |
| pertussis immune globulin | A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically. Synonym: pertussis immunoglobulin. (05 Mar 2000) |
| poliomyelitis immune globulin | A sterile solution of globulin's that contains those antibodies normally present in adult human blood; it is a passive immunologic agent that attenuates or prevents poliomyelitis, measles, and infectious hepatitis, and confers temporary but significant protection against paralytic polio. Synonym: poliomyelitis immunoglobulin. (05 Mar 2000) |
| primary immune response | <immunology> The immune response to the first challenge by a particular antigen. Usually less extensive than the secondary immune response, being slower and shorter lived with smaller amounts of lower affinity antibody being produced. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|